Wolfram, Digital Sign Deal To Sell Mathematica

Wolfram Research Inc. has taken a major step to broaden distribution of its Mathematica software system. signing an agreement with Digital Equipment Corp. to share marketing rights to the program. Under the licensing agreement, whose terms remain confidential, both Wolfram and Digital will be able to sell the software for use on Digital VAX and RISC computer systems. Mathematica, which Wolfram Research Inc. introduced in June 1988 for personal computers, is a software package that can per

Written byKen Kalfus
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Wolfram Research Inc. has taken a major step to broaden distribution of its Mathematica software system. signing an agreement with Digital Equipment Corp. to share marketing rights to the program.

Under the licensing agreement, whose terms remain confidential, both Wolfram and Digital will be able to sell the software for use on Digital VAX and RISC computer systems.

Mathematica, which Wolfram Research Inc. introduced in June 1988 for personal computers, is a software package that can perform and graphically display high-order mathematical processes. The Champaign, Ill., company was founded by theoretical physicist Stephen Wolfram, who developed the software (The Scientist, Oct. 16, 1989, page I).

Robert Leiss, a Digital distribution executive, says his company intends to market the, product through direct mail advertising, trade shows, and its direct sales force. Digital’s belief in the program’s education potential was suggested by the place it chose to announce the agreement with Wolfram: ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies